نتایج جستجو برای: ژن kras

تعداد نتایج: 23037  

2016
Jieqiong Wang Kewen Hu Jiawei Guo Feixiong Cheng Jing Lv Wenhao Jiang Weiqiang Lu Jinsong Liu Xiufeng Pang Mingyao Liu

No effective targeted therapies exist for cancers with somatic KRAS mutations. Here we develop a synthetic lethal chemical screen in isogenic KRAS-mutant and wild-type cells to identify clinical drug pairs. Our results show that dual inhibition of polo-like kinase 1 and RhoA/Rho kinase (ROCK) leads to the synergistic effects in KRAS-mutant cancers. Microarray analysis reveals that this combinat...

Journal: :Cancer research 2006
Marie Wislez Nobukazu Fujimoto Julie G Izzo Amy E Hanna Dianna D Cody Robert R Langley Hongli Tang Marie D Burdick Mitsuo Sato John D Minna Li Mao Ignacio Wistuba Robert M Strieter Jonathan M Kurie

CXCL8, a ligand for the chemokine receptor CXCR2, was recently reported to be a transcriptional target of Ras signaling, but its role in Ras-induced tumorigenesis has not been fully defined. Here, we investigated the role of KC and MIP-2, the murine homologues of CXCL8, in Kras(LA1) mice, which develop lung adenocarcinoma owing to somatic activation of the KRAS oncogene. We first investigated b...

2014
Tai Feng Hsu Ming Yii Huang Hsueh Chiao Liu Jia Yuan Chang Jian Jhang Huang Shiu Ru Lin

The KRAS mutation test is recommended that it may determine which patients with advanced colorectal or lung cancer are eligible for antiEGFR targeted therapies. Traditional molecular techniques such as polymerase chain reaction (PCR) combined direct sequencing are limited by the difficulty of obtaining patients’ cancer tissues for analysis. Finding an alternative method to detect KRAS gene muta...

Journal: :Blood 2014
Patricia S Hähnel Birgit Enders Daniel Sasca Wynand P Roos Bernd Kaina Lars Bullinger Matthias Theobald Thomas Kindler

Activating KRAS mutations are detected in a substantial number of hematologic malignancies. In a murine T-cell acute lymphoblastic leukemia (T-ALL) model, we previously showed that expression of oncogenic Kras induced a premalignant state accompanied with an arrest in T-cell differentiation and acquisition of somatic Notch1 mutations. These findings prompted us to investigate whether the expres...

2017
Weiran Liu Yuesong Yin Jun Wang Bowen Shi Lianmin Zhang Dong Qian Chenguang Li Hua Zhang Shengguang Wang Jinfang Zhu Liuwei Gao Qiang Zhang Bin Jia Ligang Hao Changli Wang Bin Zhang

As shortened telomeres inhibit tumor formation and prolong life span in a KrasG12D mouse lung cancer model, we investigated the implications of telomerase in Kras-mutant NSCLC. We found that Kras mutations increased TERT (telomerase reverse transcriptase) mRNA expression and telomerase activity and telomere length in both immortalized bronchial epithelial cells (BEAS-2B) and lung adenocarcinoma...

2012
SHOZO MIYANO KISABURO HANAZAWA TOSHIAKI KITABATAKE MINORU FUJISAWA KUNIAKI KOJIMA

We investigated the effectiveness of peptide nucleic acid (PNA) clamp PCR for detecting KRAS mutations in peripheral blood samples of colorectal cancer (CRC) patients. We compared KRAS point mutations between tumour tissue and blood samples. Forty-two patients were included in this study. We observed KRAS mutations in formalin-fixed, paraffin-embedded tissues by PCR direct sequencing and in blo...

Journal: :Blood 2009
Jing Zhang Jing Wang Yangang Liu Harwin Sidik Ken H Young Harvey F Lodish Mark D Fleming

KRAS is often mutated in human hematopoietic malignancies, including juvenile myelomonocytic leukemia (JMML) and T-cell lymphoblastic leukemia/lymphoma (TLL/L). However, the exact role and function of oncogenic KRAS mutations in the initiation and progression of JMML and TLL/L remain elusive. Here, we report the use of a mouse bone marrow transplantation model to study oncogenic Kras-induced le...

2018
Wei Jiang Libing Xiang Xuan Pei Tiancong He Xuxia Shen Xiaohua Wu Huijuan Yang

OBJECTIVE The predictive and prognostic role of KRAS mutations in cervical cancer remains inconclusive. The aim of this study was to explore the clinicopathological and prognostic relevance of KRAS mutations in invasive cervical cancers (ICC). METHODS Reverse transcription polymerase chain reaction (PCR) and Sanger sequencing were employed to detect KRAS mutations in 876 ICC patients. Quantit...

2016
D. P. Modest I. Ricard V. Heinemann S. Hegewisch-Becker W. Schmiegel R. Porschen S. Stintzing U. Graeven D. Arnold L. F. von Weikersthal C. Giessen-Jung A. Stahler H. J. Schmoll A. Jung T. Kirchner A. Tannapfel A. Reinacher-Schick

BACKGROUND To explore the impact of KRAS, NRAS and BRAF mutations as well as KRAS mutation variants in patients with metastatic colorectal cancer (mCRC) receiving first-line therapy. PATIENTS AND METHODS A total of 1239 patients from five randomized trials (FIRE-1, FIRE-3, AIOKRK0207, AIOKRK0604, RO91) were included into the analysis. Outcome was evaluated by the Kaplan-Meier method, log-rank...

2012
Krishna R. Kalari David Rossell Brian M. Necela Yan W. Asmann Asha Nair Saurabh Baheti Jennifer M. Kachergus Curtis S. Younkin Tiffany Baker Jennifer M. Carr Xiaojia Tang Michael P. Walsh High-Seng Chai Zhifu Sun Steven N. Hart Alexey A. Leontovich Asif Hossain Jean-Pierre Kocher Edith A. Perez David N. Reisman Alan P. Fields E. Aubrey Thompson

KRAS mutations are highly prevalent in non-small cell lung cancer (NSCLC), and tumors harboring these mutations tend to be aggressive and resistant to chemotherapy. We used next-generation sequencing technology to identify pathways that are specifically altered in lung tumors harboring a KRAS mutation. Paired-end RNA-sequencing of 15 primary lung adenocarcinoma tumors (8 harboring mutant KRAS a...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید